Where is Linical located?

Linical is headquartered in Osaka, Japan. It is registered at Düsseldorfer Str. 15-17, 60329 Frankfurt am Main.

How many employees does Linical have?

As of Apr 30, 2026, the latest employee count at Linical is 321.

Is Linical a funded company?

Linical is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Linical rank among its competitors?

Linical ranks 10th amongst 105 active competitors, of which 13 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Tharimmune, which secured $545M in Nov, 2025.

Who are the top competitors of Linical?

Linical's top competitors include CancerVax, Tharimmune and OnCusp. Among them, Tharimmune secured the most recent funding round in November, 2025.

Linical - 2026 Company Profile, Funding & Competitors

Company Details

Linical is a full-service CRO, headquartered in Japan and operations in 20+ countries which includes all major markets in the Asia-Pacific, North American and European regions. Their service portfolio includes project management, clinical monitoring, data management, statistical analysis, medical writing, pharmacovigilance, regulatory affairs, medical management. They offer their clinical trial services in a wide range of therapeutic areas and claim to have expertise in oncology, CNS, immunology, respiratory, allergy, endocrinology and GI disorders.

Website: www.linical.com/
Registered Address: Düsseldorfer Str. 15-17, 60329 Frankfurt am Main

Key Metrics

Founded Year

2005

Location

Osaka, Japan

Stage

Public

Investors

Japan Asia Investment & 1 more

Ranked

10^th among 105 active competitors

Employee Count

321 as on Apr 30, 2026

Investment & Acquisitions

Accelovance

Similar Companies

CancerVax & 117 more

Exit Details

Public

View Linical's full profile

Linical is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
LINICAL Czech Republic s.r.o. CIN: 06420451 , Czech Republic, Active	Sep 08, 2017	-	-
LINICAL Europe Holding GmbH CIN: D2601_HRB186100 , Germany, Active	Jun 07, 2010	-	-

Linical got listed on Oct 27, 2008.

Click here to take a look at Linical's IPO in detail

Linical is a funded company. Linical has 2 institutional investors.

View details of Linical's funding rounds and investors

Linical's employee count trend

Linical has 321 employees as of Apr 26. Here is Linical's employee count trend over the years:

Uncover Linical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Linical include CancerVax, Tharimmune and OnCusp. Here is the list of Top 10 competitors of Linical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CancerVax 1998, Carlsbad (United States), Series B	Limited information available	$58M	Athenian Venture Partners, endpointgroup.com ... & 11 others	48/100
2nd	Tharimmune 2023, Bridgewater (United States), Public	Clinical-stage biotechnology company developing a portfolio of therapeutic candidates for rare, inflammatory, and oncologic conditions	-	DRW Trading Group, Liberty City Ventures ... & 25 others	47/100
3rd	OnCusp 2021, New York City (United States), Series A	CRO offering clinical development services for oncology drugs	$139M	Novo Holdings, Orbimed & 8 others	46/100
4th	Oncotherapeutics 1988, West Hollywood (United States), Acquired	CRO focused on community oncology research, improving cancer therapies' clinical utility	$8.3M	Domain Associates, TVM Capital	44/100
5th	Medivir 1998, Sweden, Public	Medivir - Science working wonders	-	-	41/100
6th	Vivia Biotech 2007, Tres Cantos (Spain), Series A	Developer of precision medicine test for hematologic cancers	$7.52M	Suanfarma, Clave	39/100
7th	Medelis 2003, Nashville (United States), Acquired	Oncology CRO providing expert clinical trial management for drug development	-	-	38/100
8th	EmeritusDX 2020, Irvine (United States), Unfunded	CRO focused on providing cancer drug development services	-	-	38/100
9th	Aster Insights 2006, Tampa (United States), Series C	Provider of contract based oncology clinical trial services	$75M	Clayton Dubilier & Rice, Hearst & 6 others	37/100
10th	Linical 2005, Osaka (Japan), Public	Full service CRO with presence in 20+ countries	-	Japan Asia Investment, SBIC West Japan	37/100